Biomerica, Inc. (BMRA)
| Market Cap | 50.89M |
| Revenue (ttm) | 10.59M |
| Net Income (ttm) | -6.98M |
| Shares Out | 12.85M |
| EPS (ttm) | -0.45 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 157,563 |
| Open | 4.14 |
| Previous Close | 3.95 |
| Day's Range | 3.77 - 4.30 |
| 52-Week Range | 3.30 - 8.15 |
| Beta | -0.69 |
| Analysts | Buy |
| Price Target | 13.00 (+228.3%) |
| Earnings Date | n/a |
About BMRA
Biomerica, Inc., a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, or fecal specimens from patients in the diagnosis of various diseases and other medical complications; or to measure the level of specific bacteria, hormones, antibodies, antigens, or other substances, which exist in the patient's body and stools or blood in extremely ...
Financial Performance
Financial StatementsAnalyst Forecast
According to one analyst, the rating for Biomerica stock is "Buy" and the 12-month stock price forecast is 13.00.
News
Biomerica Reports Record Financial Results for Fiscal Second Quarter ended November 30, 2021
IRVINE, Calif., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products, today reported its second quarter fiscal 2022 financial ...
Biomerica Announces Preliminary Second Quarter Revenue Increase of Approximately 238%, to Approximately $4.6 Million
IRVINE, Calif., Dec. 16, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced certain preliminary financial results for the second fiscal quarter ended November 30, 20...
Biomerica Forms Scientific Advisory Board for Colorectal Cancer Screening
IRVINE, Calif., Nov. 19, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced that Dr. Brooks Cash, one the nation's most recognized leaders in Gastroenterology medicine, has agreed to...
Biomerica Receives Notice of Allowance from Canadian Patent Office for Patent Covering Irritable Bowel Syndrome (IBS)...
IRVINE, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) today announced that the Canadian Patent Office has issued a notice of allowance for Biomerica's patent application perta...
Biomerica Launches New Website for Its Aware® Breast Exam Device
IRVINE, Calif. , Oct. 29, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that in conjunction with Breast Cancer Awareness month, which takes place each October, ...
Recap: Biomerica Q1 Earnings
Biomerica(NASDAQ:BMRA) stock rose by 2.53% on Monday after the company reported its Q1 earnings results on Friday, October 15, 2021 at 06:30 AM. Here's what investors need to know about the announcement.
Walmart to Begin Nationwide In-Store Sales of Biomerica's EZ Detect™ Colorectal Screening Test
IRVINE, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that Walmart has begun in-store sales and rollout of the Company's EZ Detect™ colorectal ...
Biomerica Reports Results for Fiscal First Quarter ended August 31, 2021
IRVINE, Calif., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products, today reported its first quarter fiscal 2022 financial r...
Short Squeeze Stocks: BMRA, PROG and 3 Other Stocks Experts Think Are Ready to Pop
According to Fintel, here are five short squeeze stocks that are among the most likely to see a squeeze attempt moving forward. The post Short Squeeze Stocks: BMRA, PROG and 3 Other Stocks Experts Think...
5 Short Squeeze Candidates To Watch: Aterian, Marin On List Again, Plus 3 New Small-Cap Medical Plays
Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next GameStop Corp (NYSE: GME) and AMC Entertainment Holdings Inc (NYSE: AMC), two stocks that attracted s...
BMRA Stock: The Big Walmart Deal That Has Biomerica Investors Smiling Today
Biomerica (BMRA) stock is surging higher on Friday thanks to a new deal with Walmart (WMT) concerning its EZ Detect product. The post BMRA Stock: The Big Walmart Deal That Has Biomerica Investors Smilin...
Biomerica's Shares Gain As Its Colon Disease Screening Test Goes For Sale At Walmart Online
Biomerica Inc (NASDAQ:BMRA) has entered into a Supplier Agreement with Walmart Inc (NYSE:WMT) to sell its EZ Detect colorectal disease screening test within the Walmart retail system. Beginning this we...
Walmart Now Selling Biomerica's EZ Detect™ Colorectal Screening Test
IRVINE, Calif., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that it has entered into a General Merchandise Supplier Agreement with Walmart for the sa...
Biomerica expects Completion of Patient Enrollment for its InFoods® Diagnostic-Guided Therapy Irritable Bowel Syndrom...
IRVINE, Calif., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced it expects final patient enrollment in its endpoint clinical trial for its InFoods® diagnostic-guided ther...
Biomerica Reports Fiscal 2021 Year End Results
IRVINE, Calif., Aug. 27, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products, today reported its fiscal 2021 financial results. During...
Biomerica Announces Notice of Allowance for Patent on Product used to Diagnose and Treat Depression
IRVINE, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) announced today that the Japanese Patent Office has issued a notice of allowance for Biomerica's first patent pertaining t...
Biomerica Launches New Website For Its EZ Detect™ Colorectal Disease Screening Test
IRVINE, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced the launch of their new website for their EZ Detect™ Colon Disease Test product at https://ezdetect.com. T...
Biomerica Signs Exclusive Distribution Agreement in Canada for its New and Proprietary Helicobacter Pylori (H. pylori...
IRVINE, Calif., June 24, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced that it has signed an exclusive five-year distribution agreement with a Canadian partner for the distribut...
Biomerica Receives Notice of Allowance from Mexican Patent Office for Irritable Bowel Syndrome Food Sensitivity Testi...
IRVINE, Calif., June 15, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) today announced that the Mexican Patent Office has issued a notice of allowance for Biomerica's patent application pertai...
Biomerica to Participate in Upcoming Investor Conferences
IRVINE, Calif., June 04, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today announced that it will be participating in two upcoming investor c...
Biomerica's Fast 15-Minute Easy to Use COVID-19 Antigen Test Now Available With Simple Nasal Swab
IRVINE, Calif., May 11, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, announced that its new COVID-19 Antigen Rapid Test can now be performed w...
Biomerica Reports 208% Increase In Q3 Fiscal 2021 Sales, Over Q3 Fiscal 2020
IRVINE, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today announced its fiscal third quarter 2021 financial results for the...
Biomerica Reports Fiscal 2021 Second Quarter Financial Results and Provides Business Update
IRVINE, Calif., Jan. 15, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today announced financial results for its second quarter of fiscal year ...
Biomerica News: 10 Things for Potential BMRA Stock Investors to Know Today
Biomerica (BMRA) news for Tuesday concerning its rapid test for the novel coronavirus coming to new countries has BMRA stock on the rise. The post Biomerica News: 10 Things for Potential BMRA Stock Inve...
Biomerica's Fast 15-Minute Simple to Use Covid-19 Antigen Rapid Test Receives CE Mark
IRVINE, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced medical products, today announced it has received CE Mark for its new COVID-19 Rapid Antig...